Inflammatory Disorders - Part A

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.

• 1. Using evasins to target the chemokine network in inflammation Shoumo Bhattacharya and Akane Kawamura2. Biological functions and clinical implications of interleukin-34 in inflammatory diseasesYun Ge, Man Huang, Xiao-mei Zhu, and Yong-ming Yao3. Pattern recognition receptors as potential drug targets in inflammatory disordersDeclan P. McKernan4. Glycosylation changes in inflammatory diseasesSophie Groux-Degroote, Sumeyye Cavdarli, Kenji Uchimura, Fabrice Allain, and Philippe Delannoy5. Inflammatory bowel disease and targeted oral anti-TNFa therapyOwen R. Griffiths, John Landon, Ruth E. Coxon, Keith Morris, Philip James, and Rachel Adams6. Interplay between inflammation and cancerRekha Khandia and Ashok Munjal7. Microglial NLRP3 inflammasome activation in multiple sclerosis Melis Olcum, Bora Tastan, Cagla Kiser, Sermin Genc and Kursad Genc8. Sleep deprivation, oxidative stress and inflammationFatin Atrooz and Samina Salim